Wegovy may have highest ‘eye stroke’ and sight loss risk among semaglutide GLP-1 agonists
by British Medical Journal edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of “eye stroke” (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports […]
